| ID | Sequence | Length | GC content |
|---|---|---|---|
| AAGCACUGCCUGUAAAGCCCUCGCAUGAGAGGCCAGCCUGCUAGGGAAA… | 2880 nt | 0.4177 | |
| AAGCACUGCCUGUAAAGCCCUCGCAUGAGAGGCCAGCCUGCUAGGGAAA… | 2887 nt | 0.4226 | |
| AAGCACUGCCUGUAAAGCCCUCGCAUGAGAGGCCAGCCUGCUAGGGAAA… | 2538 nt | 0.4208 | |
| AAGCACUGCCUGUAAAGCCCUCGCAUGAGAGGCCAGCCUGCUAGGGAAA… | 2778 nt | 0.4208 |
Predicted to enable calcium ion binding activity; collagen binding activity; and extracellular matrix binding activity. Predicted to be involved in regulation of synapse organization. Located in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
A study in human cardiac tissue from ischemic cardiomyopathy patients identified the SPARCL1 as a gene with important roles in disease and classified it as a potential druggable target for heart disease [Simonson et al. DOI:10.1016/j.celrep.2023.112086].